| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_DLGAP4_0001800 | Exon-Exon | chr20:35060049-35075340 | chr20:36431646-36446937 | 407 nt | 0.6265 |
| hsa_DLGAP4_0001900 | Exon-Exon | chr20:35060054-35061119 | chr20:36431651-36432716 | 1066 nt | 0.6548 |
| hsa_DLGAP4_0002000 | Exon-Exon | chr20:35060054-35075340 | chr20:36431651-36446937 | 1715 nt | 0.6589 |
| hsa_DLGAP4_0002100 | Intron-Exon-Intron | chr20:35064437-35064753 | chr20:36436034-36436350 | 317 nt | 0.7098 |
| hsa_DLGAP4_0002200 | Exon-Exon | chr20:35064512-35075340 | chr20:36436109-36446937 | 649 nt | 0.6656 |
| hsa_DLGAP4_0002300 | Exon-Exon | chr20:35068157-35075340 | chr20:36439754-36446937 | 121 nt | 0.6116 |
| hsa_DLGAP4_0002400 | Intron-Exon-Intron | chr20:35068157-35080306 | chr20:36439754-36451903 | 115 nt | 0.6174 |
| hsa_DLGAP4_0002800 | Intron-Intron | chr20:35080861-35081821 | chr20:36452458-36453418 | 961 nt | 0.4870 |
| hsa_DLGAP4_0002900 | Intron-Intron | chr20:35082598-35085672 | chr20:36454195-36457269 | 250 nt | 0.3600 |
| hsa_DLGAP4_0003000 | Intron-Intron | chr20:35088288-35088528 | chr20:36459885-36460125 | 241 nt | 0.4855 |
A study in mice and humans demonstrated that the circDLGAP4 is significantly decreased in plasma after acute ischemic stroke and in a mouse stroke model, suggesting its potential as a therapeutic target for myocardial ischemia/reperfusion injury [Tian et al. DOI:10.3390/molecules26041155].